Aktiekurs

Datum	Shanghai Pharmaceuticals Holding Co Omsättning	Shanghai Pharmaceuticals Holding Co EBIT	Shanghai Pharmaceuticals Holding Co Vinst
2026e	357,23 Mdk. undefined	12,63 Mdk. undefined	3,50 Mdk. undefined
2025e	322,76 Mdk. undefined	11,21 Mdk. undefined	3,04 Mdk. undefined
2024e	291,16 Mdk. undefined	9,86 Mdk. undefined	2,70 Mdk. undefined
2023	260,30 Mdk. undefined	8,86 Mdk. undefined	3,77 Mdk. undefined
2022	231,98 Mdk. undefined	8,32 Mdk. undefined	5,62 Mdk. undefined
2021	215,82 Mdk. undefined	7,80 Mdk. undefined	5,09 Mdk. undefined
2020	191,91 Mdk. undefined	7,74 Mdk. undefined	4,50 Mdk. undefined
2019	186,57 Mdk. undefined	7,37 Mdk. undefined	4,08 Mdk. undefined
2018	159,08 Mdk. undefined	5,71 Mdk. undefined	3,88 Mdk. undefined
2017	130,85 Mdk. undefined	5,06 Mdk. undefined	3,52 Mdk. undefined
2016	120,77 Mdk. undefined	3,74 Mdk. undefined	3,20 Mdk. undefined
2015	105,52 Mdk. undefined	3,62 Mdk. undefined	2,88 Mdk. undefined
2014	92,40 Mdk. undefined	3,21 Mdk. undefined	2,59 Mdk. undefined
2013	78,22 Mdk. undefined	2,79 Mdk. undefined	2,24 Mdk. undefined
2012	68,08 Mdk. undefined	2,55 Mdk. undefined	2,05 Mdk. undefined
2011	54,90 Mdk. undefined	2,34 Mdk. undefined	2,04 Mdk. undefined
2010	38,53 Mdk. undefined	1,76 Mdk. undefined	1,27 Mdk. undefined
2009	31,26 Mdk. undefined	1,28 Mdk. undefined	1,30 Mdk. undefined
2008	16,55 Mdk. undefined	208,00 Mkr. undefined	82,00 Mkr. undefined
2007	13,92 Mdk. undefined	220,00 Mkr. undefined	66,00 Mkr. undefined
2006	12,64 Mdk. undefined	120,00 Mkr. undefined	−39,00 Mkr. undefined
2005	10,70 Mdk. undefined	90,00 Mkr. undefined	51,00 Mkr. undefined
2004	10,82 Mdk. undefined	121,00 Mkr. undefined	90,00 Mkr. undefined

	Omsättning	EBIT	Vinst
2004	10,82 Mdk. CNY	121,00 Mkr. CNY	90,00 Mkr. CNY
2005	10,70 Mdk. CNY	90,00 Mkr. CNY	51,00 Mkr. CNY
2006	12,64 Mdk. CNY	120,00 Mkr. CNY	−39,00 Mkr. CNY
2007	13,92 Mdk. CNY	220,00 Mkr. CNY	66,00 Mkr. CNY
2008	16,55 Mdk. CNY	208,00 Mkr. CNY	82,00 Mkr. CNY
2009	31,26 Mdk. CNY	1,28 Mdk. CNY	1,30 Mdk. CNY
2010	38,53 Mdk. CNY	1,76 Mdk. CNY	1,27 Mdk. CNY
2011	54,90 Mdk. CNY	2,34 Mdk. CNY	2,04 Mdk. CNY
2012	68,08 Mdk. CNY	2,55 Mdk. CNY	2,05 Mdk. CNY
2013	78,22 Mdk. CNY	2,79 Mdk. CNY	2,24 Mdk. CNY
2014	92,40 Mdk. CNY	3,21 Mdk. CNY	2,59 Mdk. CNY
2015	105,52 Mdk. CNY	3,62 Mdk. CNY	2,88 Mdk. CNY
2016	120,77 Mdk. CNY	3,74 Mdk. CNY	3,20 Mdk. CNY
2017	130,85 Mdk. CNY	5,06 Mdk. CNY	3,52 Mdk. CNY
2018	159,08 Mdk. CNY	5,71 Mdk. CNY	3,88 Mdk. CNY
2019	186,57 Mdk. CNY	7,37 Mdk. CNY	4,08 Mdk. CNY
2020	191,91 Mdk. CNY	7,74 Mdk. CNY	4,50 Mdk. CNY
2021	215,82 Mdk. CNY	7,80 Mdk. CNY	5,09 Mdk. CNY
2022	231,98 Mdk. CNY	8,32 Mdk. CNY	5,62 Mdk. CNY
2023	260,30 Mdk. CNY	8,86 Mdk. CNY	3,77 Mdk. CNY
2024e	291,16 Mdk. CNY	9,86 Mdk. CNY	2,70 Mdk. CNY
2025e	322,76 Mdk. CNY	11,21 Mdk. CNY	3,04 Mdk. CNY
2026e	357,23 Mdk. CNY	12,63 Mdk. CNY	3,50 Mdk. CNY

Shanghai Pharmaceuticals Holding Co Bruttomarginal	Shanghai Pharmaceuticals Holding Co Vinstmarginal	Shanghai Pharmaceuticals Holding Co EBIT-marginal	Shanghai Pharmaceuticals Holding Co Vinstmarginal
2026e	11,92 %	3,54 %	0,98 %
2025e	11,92 %	3,47 %	0,94 %
2024e	11,92 %	3,39 %	0,93 %
2023	11,92 %	3,40 %	1,45 %
2022	13,14 %	3,58 %	2,42 %
2021	13,20 %	3,61 %	2,36 %
2020	14,09 %	4,03 %	2,34 %
2019	14,22 %	3,95 %	2,19 %
2018	13,96 %	3,59 %	2,44 %
2017	12,73 %	3,87 %	2,69 %
2016	11,73 %	3,10 %	2,65 %
2015	11,92 %	3,43 %	2,73 %
2014	12,24 %	3,48 %	2,80 %
2013	12,98 %	3,56 %	2,87 %
2012	13,56 %	3,75 %	3,02 %
2011	14,31 %	4,25 %	3,72 %
2010	17,71 %	4,57 %	3,29 %
2009	18,71 %	4,08 %	4,15 %
2008	8,60 %	1,26 %	0,50 %
2007	8,63 %	1,58 %	0,47 %
2006	8,26 %	0,95 %	−0,31 %
2005	6,41 %	0,84 %	0,48 %
2004	9,24 %	1,12 %	0,83 %

	Bruttomarginal	EBIT-marginal	Vinstmarginal
2004	9,24 %	1,12 %	0,83 %
2005	6,41 %	0,84 %	0,48 %
2006	8,26 %	0,95 %	−0,31 %
2007	8,63 %	1,58 %	0,47 %
2008	8,60 %	1,26 %	0,50 %
2009	18,71 %	4,08 %	4,15 %
2010	17,71 %	4,57 %	3,29 %
2011	14,31 %	4,25 %	3,72 %
2012	13,56 %	3,75 %	3,02 %
2013	12,98 %	3,56 %	2,87 %
2014	12,24 %	3,48 %	2,80 %
2015	11,92 %	3,43 %	2,73 %
2016	11,73 %	3,10 %	2,65 %
2017	12,73 %	3,87 %	2,69 %
2018	13,96 %	3,59 %	2,44 %
2019	14,22 %	3,95 %	2,19 %
2020	14,09 %	4,03 %	2,34 %
2021	13,20 %	3,61 %	2,36 %
2022	13,14 %	3,58 %	2,42 %
2023	11,92 %	3,40 %	1,45 %
2024e	11,92 %	3,39 %	0,93 %
2025e	11,92 %	3,47 %	0,94 %
2026e	11,92 %	3,54 %	0,98 %

Datum	Shanghai Pharmaceuticals Holding Co Omsättning per aktie	Shanghai Pharmaceuticals Holding Co EBIT per aktie	Shanghai Pharmaceuticals Holding Co Vinst per aktie
2026e	184,95 undefined	0 undefined	1,81 undefined
2025e	167,10 undefined	0 undefined	1,57 undefined
2024e	150,74 undefined	0 undefined	1,40 undefined
2023	70,33 undefined	2,39 undefined	1,02 undefined
2022	66,61 undefined	2,39 undefined	1,61 undefined
2021	75,85 undefined	2,74 undefined	1,79 undefined
2020	67,43 undefined	2,72 undefined	1,58 undefined
2019	65,83 undefined	2,60 undefined	1,44 undefined
2018	56,23 undefined	2,02 undefined	1,37 undefined
2017	48,66 undefined	1,88 undefined	1,31 undefined
2016	44,91 undefined	1,39 undefined	1,19 undefined
2015	39,24 undefined	1,35 undefined	1,07 undefined
2014	34,36 undefined	1,19 undefined	0,96 undefined
2013	29,09 undefined	1,04 undefined	0,83 undefined
2012	25,32 undefined	0,95 undefined	0,76 undefined
2011	22,68 undefined	0,96 undefined	0,84 undefined
2010	19,33 undefined	0,88 undefined	0,64 undefined
2009	15,69 undefined	0,64 undefined	0,65 undefined
2008	29,08 undefined	0,37 undefined	0,14 undefined
2007	24,46 undefined	0,39 undefined	0,12 undefined
2006	22,21 undefined	0,21 undefined	−0,07 undefined
2005	18,80 undefined	0,16 undefined	0,09 undefined
2004	19,01 undefined	0,21 undefined	0,16 undefined

	Omsättning per aktie	EBIT per aktie	Vinst per aktie
2004	19,01 CNY	0,21 CNY	0,16 CNY
2005	18,80 CNY	0,16 CNY	0,09 CNY
2006	22,21 CNY	0,21 CNY	−0,07 CNY
2007	24,46 CNY	0,39 CNY	0,12 CNY
2008	29,08 CNY	0,37 CNY	0,14 CNY
2009	15,69 CNY	0,64 CNY	0,65 CNY
2010	19,33 CNY	0,88 CNY	0,64 CNY
2011	22,68 CNY	0,96 CNY	0,84 CNY
2012	25,32 CNY	0,95 CNY	0,76 CNY
2013	29,09 CNY	1,04 CNY	0,83 CNY
2014	34,36 CNY	1,19 CNY	0,96 CNY
2015	39,24 CNY	1,35 CNY	1,07 CNY
2016	44,91 CNY	1,39 CNY	1,19 CNY
2017	48,66 CNY	1,88 CNY	1,31 CNY
2018	56,23 CNY	2,02 CNY	1,37 CNY
2019	65,83 CNY	2,60 CNY	1,44 CNY
2020	67,43 CNY	2,72 CNY	1,58 CNY
2021	75,85 CNY	2,74 CNY	1,79 CNY
2022	66,61 CNY	2,39 CNY	1,61 CNY
2023	70,33 CNY	2,39 CNY	1,02 CNY
2024e	150,74 CNY	0 CNY	1,40 CNY
2025e	167,10 CNY	0 CNY	1,57 CNY
2026e	184,95 CNY	0 CNY	1,81 CNY

	Antal aktier
2004	569,00 Mkr. Aktien
2005	569,00 Mkr. Aktien
2006	569,00 Mkr. Aktien
2007	569,00 Mkr. Aktien
2008	569,00 Mkr. Aktien
2009	1,99 Mdk. Aktien
2010	1,99 Mdk. Aktien
2011	2,42 Mdk. Aktien
2012	2,69 Mdk. Aktien
2013	2,69 Mdk. Aktien
2014	2,69 Mdk. Aktien
2015	2,69 Mdk. Aktien
2016	2,69 Mdk. Aktien
2017	2,69 Mdk. Aktien
2018	2,83 Mdk. Aktien
2019	2,83 Mdk. Aktien
2020	2,85 Mdk. Aktien
2021	2,85 Mdk. Aktien
2022	3,48 Mdk. Aktien
2023	3,70 Mdk. Aktien
2024e	3,70 Mdk. Aktien
2025e	3,70 Mdk. Aktien
2026e	3,70 Mdk. Aktien

Datum	Shanghai Pharmaceuticals Holding Co Utdelning
2026e	0,65 undefined
2025e	0,65 undefined
2024e	0,65 undefined
2023	0,61 undefined
2022	0,42 undefined
2021	0,48 undefined
2020	0,44 undefined
2019	0,41 undefined
2018	0,38 undefined
2017	0,36 undefined
2016	0,33 undefined
2015	0,29 undefined
2014	0,26 undefined
2013	0,24 undefined
2012	0,16 undefined
2011	0,14 undefined
2010	0,10 undefined
2009	0,05 undefined
2008	0,05 undefined
2006	0,10 undefined
2005	0,07 undefined
2004	0,07 undefined

	Utdelning	Utdelning (uppskattning)
2004	0,07 CNY	0 CNY
2005	0,07 CNY	0 CNY
2006	0,10 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0,05 CNY	0 CNY
2009	0,05 CNY	0 CNY
2010	0,10 CNY	0 CNY
2011	0,14 CNY	0 CNY
2012	0,16 CNY	0 CNY
2013	0,24 CNY	0 CNY
2014	0,26 CNY	0 CNY
2015	0,29 CNY	0 CNY
2016	0,33 CNY	0 CNY
2017	0,36 CNY	0 CNY
2018	0,38 CNY	0 CNY
2019	0,41 CNY	0 CNY
2020	0,44 CNY	0 CNY
2021	0,48 CNY	0 CNY
2022	0,42 CNY	0 CNY
2023	0,61 CNY	0 CNY
2024e	0 CNY	0,65 CNY
2025e	0 CNY	0,65 CNY
2026e	0 CNY	0,65 CNY

Datum	Shanghai Pharmaceuticals Holding Co Utdelningsandel
2026e	26,67 %
2025e	26,51 %
2024e	26,59 %
2023	26,90 %
2022	26,04 %
2021	26,82 %
2020	27,85 %
2019	28,47 %
2018	27,74 %
2017	27,48 %
2016	27,73 %
2015	27,10 %
2014	27,08 %
2013	28,92 %
2012	21,05 %
2011	16,67 %
2010	15,94 %
2009	6,92 %
2008	35,71 %
2007	26,90 %
2006	−148,81 %
2005	74,07 %
2004	46,87 %

	Utdelningsandel
2004	46,87 %
2005	74,07 %
2006	−148,81 %
2007	26,90 %
2008	35,71 %
2009	6,92 %
2010	15,94 %
2011	16,67 %
2012	21,05 %
2013	28,92 %
2014	27,08 %
2015	27,10 %
2016	27,73 %
2017	27,48 %
2018	27,74 %
2019	28,47 %
2020	27,85 %
2021	26,82 %
2022	26,04 %
2023	26,90 %
2024e	26,59 %
2025e	26,51 %
2026e	26,67 %

Datum	EPS-prognos	EPS-Aktuell	Rapportkvartal
2024-03-31	1,53	0,42 (−72,63 %)	2024 Q1
2023-12-31	0,53	−0,01 (−101,90 %)	2023 Q4
2023-09-30	0,45	0,32 (−29,59 %)	2023 Q3
2023-06-30	0,65	0,30 (−53,59 %)	2023 Q2
2023-03-31	0,40	0,41 (1,49 %)	2023 Q1
2022-12-31	−0,29	0,16 (154,63 %)	2022 Q4
2022-09-30	0,36	0,30 (−17,49 %)	2022 Q3
2022-06-30	0,45	0,66 (45,46 %)	2022 Q2
2022-03-31	0,57	0,44 (−22,21 %)	2022 Q1
2021-12-31	0,24	0,21 (−13,37 %)	2021 Q4
2021-09-30	0,53	0,32 (−39,07 %)	2021 Q3
2021-06-30	0,68	0,51 (−24,17 %)	2021 Q2
2021-03-31	0,51	0,75 (48,51 %)	2021 Q1
2020-12-31	0,40	0,31 (−23,27 %)	2020 Q4
2020-09-30	0,26	0,41 (56,13 %)	2020 Q3
2020-06-30	0,45	0,49 (7,81 %)	2020 Q2
2020-03-31	0,38	0,37 (−1,52 %)	2020 Q1
2019-12-31	0,36	0,24 (−32,71 %)	2019 Q4
2019-09-30	0,37	0,39 (6,18 %)	2019 Q3
2019-06-30	0,41	0,41 (−0,23 %)	2019 Q2
2019-03-31	0,41	0,40 (−4,30 %)	2019 Q1
2018-12-31	0,30	0,18 (−39,93 %)	2018 Q4
2018-09-30	0,31	0,47 (51,33 %)	2018 Q3
2018-06-30	0,29	0,36 (21,54 %)	2018 Q2
2018-03-31	0,37	0,37 (−2,19 %)	2018 Q1
2017-12-31	0,30	0,31 (1,54 %)	2017 Q4
2017-09-30	0,29	0,28 (−2,20 %)	2017 Q3
2017-06-30	0,46	0,34 (−25,36 %)	2017 Q2
2017-03-31	0,34	0,37 (7,93 %)	2017 Q1
2016-12-31	0,30	0,27 (−7,84 %)	2016 Q4
2016-09-30	0,29	0,27 (−5,97 %)	2016 Q3
2016-06-30	0,32	0,31 (−3,08 %)	2016 Q2
2016-03-31	0,28	0,33 (18,52 %)	2016 Q1
2015-12-31	0,28	0,26 (−8,19 %)	2015 Q4
2015-09-30	0,26	0,24 (−7,09 %)	2015 Q3
2015-06-30	0,32	0,30 (−8,19 %)	2015 Q2
2015-03-31	0,26	0,27 (3,96 %)	2015 Q1
2014-12-31	0,22	0,25 (14,96 %)	2014 Q4
2014-09-30	0,22	0,22 (1,05 %)	2014 Q3
2014-06-30	0,27	0,27 (−0,93 %)	2014 Q2
2014-03-31	0,24	0,22 (−10,80 %)	2014 Q1
2013-12-31	0,21	0,21 (−1,92 %)	2013 Q4
2013-09-30	0,22	0,18 (−15,78 %)	2013 Q3
2013-06-30	0,22	0,21 (−5,52 %)	2013 Q2
2012-12-31	0,18	0,19 (2,27 %)	2012 Q4
2011-09-30	0,19	0,15 (−20,27 %)	2011 Q3
2011-06-30	0,21	0,06 (−72,18 %)	2011 Q2

%	Namn	Aktier	Förändring	Datum
37,10 %	Shanghai Pharmaceutical (Group) Co. Ltd.	716 516 039	0	2023-12-31
34,46 %	Yunnan Baiyao Group Co., Ltd.	665 626 796	0	2023-12-31
32,62 %	Shanghai Industrial Investment (Holdings) Co., Ltd.	629 987 798	220 686 000	2023-12-31
2,31 %	Shanghai Guosheng (Group) Co., Ltd.	44 632 100	23 762 800	2023-12-31
1,12 %	Yinhua Fund Management Co., Ltd.	21 712 597	10 111 375	2023-12-31
0,87 %	E Fund Management Co. Ltd.	16 734 637	−784 660	2023-12-31
0,64 %	Orient Securities Asset Management Company Limited	12 449 700	12 449 700	2023-06-30
0,57 %	Fullgoal Fund Management Co., Ltd.	11 000 000	118 000	2023-12-31
0,56 %	China Universal Asset Management Co., Ltd.	10 839 871	−1 102 100	2023-12-31
0,46 %	Huatai-PineBridge Fund Management Co., Ltd.	8 874 912	4 450 669	2023-12-31
0,46 %	China Southern Asset Management Co. Ltd.	8 860 445	−5 800	2023-12-31
0,46 %	GF Fund Management Co., Ltd.	8 801 380	−2 289 400	2023-12-31
0,44 %	Norges Bank Investment Management (NBIM)	8 406 130	−445 828	2023-12-31
0,36 %	Lion Fund Management Co., Ltd.	6 997 832	−169 000	2023-12-31
0,29 %	The Vanguard Group, Inc.	5 613 896	0	2024-03-31
0,29 %	BlackRock Institutional Trust Company, N.A.	5 571 831	−51 300	2024-03-31
0,27 %	China Asset Management Co., Ltd.	5 254 667	946 805	2023-12-31
0,20 %	HuaAn Fund Management Co., Ltd.	3 845 988	−352 900	2023-12-31
0,18 %	INVESCO Great Wall Fund Management Co. Ltd.	3 495 355	−11 000	2023-12-31
0,17 %	BlackRock Advisors (UK) Limited	3 350 579	116 000	2024-03-31
0,16 %	Wellington Management Company, LLP	3 134 300	252 100	2024-02-29
0,13 %	CIB Fund Management Co., Ltd.	2 568 900	−59 700	2023-12-31
0,12 %	Huashang Fund Management Co., Ltd.	2 258 756	2 258 756	2023-12-31
0,11 %	Franklin Templeton Sealand Fund Management Co., Ltd.	2 054 100	−20 800	2023-12-31
0,10 %	BlackRock Investment Management, LLC	2 024 760	178 600	2023-12-31
0,09 %	Tianhong Asset Management Co., Ltd.	1 739 387	−4 300	2023-12-31
0,09 %	Charles Schwab Investment Management, Inc.	1 693 400	1 421 900	2024-03-31
0,08 %	Purekind Fund Management Co., Ltd.	1 500 010	870 010	2023-06-30
0,07 %	HSBC JinTrust Fund Management Co., Ltd.	1 392 100	−1 060 759	2023-12-31
0,07 %	Harvest Fund Management Co., Ltd.	1 373 328	0	2024-02-29
0,06 %	Geode Capital Management, L.L.C.	1 249 500	3 200	2024-02-29
0,06 %	Penghua Fund Management Co., Ltd.	1 227 500	972 700	2023-06-30
0,05 %	Guotai Junan Securities Assets Management Co., Ltd.	1 003 200	−66 200	2023-06-30
0,05 %	China Merchants Fund Management Co. Ltd.	974 217	36 800	2023-12-31
0,05 %	Bosera Asset Management Co., Ltd.	872 100	816 700	2023-12-31
0,04 %	Harvest Global Investments Limited	867 550	0	2024-03-31
0,04 %	BOC International (China) Ltd.	750 000	−50 000	2023-12-31
0,04 %	China Asset Management (Hong Kong) Limited	739 600	49 200	2024-03-31
0,04 %	Caitong Securities Asset Management Co., Ltd.	706 400	706 400	2023-06-30
0,04 %	DWS Investments UK Limited	693 169	−3 145	2024-03-31
0,04 %	Guotai Asset Management Co., Ltd.	686 108	25 500	2023-12-31
0,04 %	Hwabao WP Fund Management Co., Ltd.	679 800	−7 400	2023-12-31
0,03 %	BlackRock Financial Management, Inc.	671 700	589 400	2023-10-31
0,03 %	Rongtong Fund Management Co., Ltd.	646 000	646 000	2023-06-30
0,03 %	Everbright PGIM Fund Management Co., Ltd.	596 000	596 000	2023-06-30
0,03 %	Zheshang Fund Management Co., Ltd.	591 600	−552 438	2023-12-31
0,03 %	State Street Global Advisors (US)	567 479	326	2024-02-29
0,03 %	Changsheng Fund Management Co., Ltd.	539 337	0	2023-12-31
0,02 %	Focusbridge Investments Limited	475 000	475 000	2023-06-30
0,02 %	SWS MU Fund Management Co., Ltd.	467 524	290 000	2023-12-31
0,02 %	Swedbank Robur Fonder AB	467 300	0	2024-02-29
0,02 %	Aviva Investors Global Services Limited	422 396	164 266	2024-02-29
0,02 %	UBS Asset Management (UK) Ltd.	415 705	1 400	2024-03-31
0,02 %	Chang Xin Asset Management Co., Ltd.	399 700	57 100	2023-12-31
0,02 %	BlackRock (Singapore) Limited	390 914	92 900	2024-03-31
0,02 %	Amundi Asset Management, SAS	388 600	−88 600	2024-03-31
0,02 %	BlackRock Asset Management North Asia Limited	381 600	0	2023-12-31
0,02 %	Credit Suisse Funds AG	325 700	−6 600	2024-03-31
0,02 %	UBS Asset Management (Switzerland)	320 700	0	2024-02-29
0,02 %	Northern Trust Global Investments Limited	310 600	30 500	2024-02-29
0,02 %	California State Teachers Retirement System	304 100	103 400	2023-06-30
0,02 %	Taiping Fund Management Co., Ltd.	292 900	292 900	2023-06-30
0,01 %	State Street Global Advisors (UK) Ltd.	268 410	1	2024-03-31
0,01 %	CCB Principal Asset Management Co., Ltd.	250 654	−358 300	2023-12-31
0,01 %	JPMorgan Asset Management (China) Company Limited.	245 300	25 600	2023-06-30
0,01 %	First-Trust Fund Management Co., Ltd.	236 200	0	2023-12-31
0,01 %	Fuanda Fund Management Co., Ltd.	233 000	−47 500	2023-12-31
0,01 %	BlackRock Investment Management (UK) Ltd.	232 100	0	2024-02-29
0,01 %	Krane Funds Advisors, LLC	229 694	5 700	2024-03-31
0,01 %	Wilmington Trust Investment Management LLC	222 800	0	2024-02-29
0,01 %	Nuveen LLC	221 732	0	2024-03-31
0,01 %	Taikang Asset Management Co., Ltd.	212 300	200 100	2023-06-30
0,01 %	Tibet Eastmoney Fund Management Co., Ltd.	210 900	−22 700	2023-12-31
0,01 %	DWS Investment GmbH	202 802	−5 400	2024-03-31
0,01 %	CPIC Fund Management Co., Ltd.	196 746	−3 300	2023-12-31
0,01 %	HSBC Global Asset Management (UK) Limited	195 347	0	2024-02-29
0,01 %	Goldman Sachs Asset Management, L.P.	193 614	−5 802	2024-03-31
0,01 %	HFT Investment Management Co., Ltd.	164 200	−1 800	2023-12-31
0,01 %	Amundi Japan Ltd.	138 400	−5 400	2024-03-31
0,01 %	Mercer Global Investments Management Ltd	136 700	0	2024-03-31
0,01 %	Invesco Capital Management LLC	136 570	0	2024-03-31
0,01 %	Fubon Asset Management Company Ltd.	117 854	−10 600	2024-02-29
0,01 %	Zürcher Kantonalbank (Asset Management)	117 400	0	2024-02-29
0,01 %	Handelsbanken Kapitalförvaltning AB	112 500	0	2024-03-31
0,01 %	Pictet Asset Management Ltd.	112 300	−8 200	2023-12-31
0,01 %	Legal & General Investment Management Ltd.	111 130	0	2024-02-29
0,01 %	Truvalue Asset Management Co., Ltd.	106 900	106 900	2023-06-30
0,01 %	HSBC Global Asset Management (Hong Kong) Limited	102 745	−522 900	2023-12-31
0,01 %	BOCI-Prudential Asset Management Ltd.	100 915	800	2024-02-29
0,01 %	China Fund Management Co., Ltd.	100 000	−87 100	2023-06-30
0,01 %	Maxwealth Fund Management Co., Ltd.	98 800	91 600	2023-06-30
0,00 %	BMO Asset Management Inc.	86 236	0	2024-03-31
0,00 %	Wanjia Asset Management Co., Ltd.	85 981	−2 000	2023-12-31
0,00 %	China Life AMP Asset Management Co., Ltd	84 000	−2 000	2023-12-31
0,00 %	WCM Investment Management	83 700	−13 900	2023-12-31
0,00 %	JT Asset Management Co., Ltd.	82 500	78 300	2023-06-30
0,00 %	ABC-CA Fund Management Co., Ltd.	82 100	−110 300	2023-12-31
0,00 %	Cardano Asset Management NV	74 491	7	2024-02-29
0,00 %	Ping An Fund Management Company Limited	72 800	700	2023-12-31
0,00 %	Shen (Bo)	71 700	0	2023-12-31

Namn	Relation	Tvåveckorskorrelation	Enmånadskorrelation	Tremånaderskorrelation	Sexmånaderskorrelation	Ettårskorrelation	Tvåårskorrelation
Shenzhen Chipscreen Biosciences A	LeverantörKund	0,99	0,84	-0,03	-0,30	-	0,07
Shandong Wohua Pharm	LeverantörKund	0,99	0,92	0,68	0,59	0,66	0,28
Gan & Lee Pharmaceuticals A	LeverantörKund	0,97	0,92	0,09	-0,21	0,42	-
Shanghai Jiao Yun Gp A	LeverantörKund	0,97	0,56	0,61	0,65	0,64	0,39
Super Telecom A	LeverantörKund	0,97	0,93	0,80	0,18	0,27	-
Betta Pharmaceuticals A	LeverantörKund	0,96	0,97	0,18	-0,25	0,21	0,15
Essence Info A	LeverantörKund	0,95	0,93	-0,14	-0,14	0,12	-
Shanghai Haixin Group A	LeverantörKund	0,94	0,76	0,33	-0,07	-0,07	0,08
Enzymatica	LeverantörKund	0,93	0,76	0,53	-0,14	0,12	0,08
Greenland -A-	LeverantörKund	0,90	0,89	0,41	0,52	0,68	-

What values and corporate philosophy does Shanghai Pharmaceuticals Holding Co represent?

Shanghai Pharmaceuticals Holding Co Ltd embodies a set of values and a corporate philosophy that underpin its operations. The company believes in delivering high-quality healthcare products and services to meet the evolving needs of its customers. Shanghai Pharmaceuticals focuses on fostering innovation, maintaining integrity, and ensuring sustainable development. By prioritizing the well-being of patients and healthcare professionals, the company strives to enhance public health and contribute to society. Shanghai Pharmaceuticals' commitment to improving medical access and advancing healthcare systems reflects its dedication to delivering value and making a positive impact in the pharmaceutical industry.

In which countries and regions is Shanghai Pharmaceuticals Holding Co primarily present?

Shanghai Pharmaceuticals Holding Co Ltd operates primarily in China. As a leading pharmaceutical company based in Shanghai, China, it has established a strong presence in its home country. With an extensive network and many subsidiaries across China, Shanghai Pharmaceuticals Holding Co Ltd serves a vast market within the country. Its presence and influence in the Chinese pharmaceutical industry contribute to its position as a key player in the region.

What significant milestones has the company Shanghai Pharmaceuticals Holding Co achieved?

Shanghai Pharmaceuticals Holding Co Ltd has achieved several significant milestones in its corporate history. The company has successfully established itself as a leading player in the pharmaceutical sector in China. Shanghai Pharmaceuticals Holding Co Ltd has expanded its business operations both domestically and internationally, through strategic acquisitions and partnerships. The company has demonstrated continued growth and stability, with a diversified product portfolio and a strong presence in key therapeutic areas. Shanghai Pharmaceuticals Holding Co Ltd has consistently focused on innovation, research and development, and delivering high-quality healthcare products and services. Through its continuous efforts, the company has garnered recognition and trust from both investors and consumers alike.

What is the history and background of the company Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co Ltd, established in 1994, is a renowned Chinese pharmaceutical company. With its headquarters in Shanghai, the company has a rich history and exceptional background in the healthcare industry. Shanghai Pharmaceuticals operates across various segments, including the production, distribution, and retail of pharmaceutical and healthcare products. Over the years, it has expanded its business both domestically and internationally, becoming a leading player in China's pharmaceutical market. With a strong focus on research and development, Shanghai Pharmaceuticals has established strategic partnerships and collaborations with global pharmaceutical giants, further enhancing its position in the industry. This company's commitment to innovation, quality, and customer satisfaction has contributed to its success and widespread recognition.

Who are the main competitors of Shanghai Pharmaceuticals Holding Co in the market?

Some of the main competitors of Shanghai Pharmaceuticals Holding Co Ltd in the market include China Resources Pharmaceutical Group Limited, Jiangsu Hengrui Medicine Co Ltd, and Sinopharm Group Co Ltd.

In which industries is Shanghai Pharmaceuticals Holding Co primarily active?

Shanghai Pharmaceuticals Holding Co Ltd is primarily active in the pharmaceutical industry. As one of the leading pharmaceutical companies in China, it operates in various sectors including research and development, manufacturing, distribution, and retail. With a diversified product portfolio, Shanghai Pharmaceuticals caters to a wide range of healthcare needs, including prescription drugs, over-the-counter medications, traditional Chinese medicine, medical devices, and healthcare services. The company's strong presence and expertise in the pharmaceutical industry enable it to contribute significantly to the advancement of healthcare and improve the quality of life for individuals across China and beyond.

What is the business model of Shanghai Pharmaceuticals Holding Co?

The business model of Shanghai Pharmaceuticals Holding Co Ltd is focused on pharmaceutical production, distribution, and retail sales. As one of China's leading integrated pharmaceutical companies, Shanghai Pharmaceuticals engages in research and development, manufacturing, marketing, and sales of both innovative and generic drugs. The company operates a comprehensive supply chain, including procurement, distribution, and retailing services. By combining its strong domestic presence with international expansion, Shanghai Pharmaceuticals aims to deliver high quality and affordable healthcare products to improve public health in China and beyond.

Vilket P/E-tal har Shanghai Pharmaceuticals Holding Co 2024?

P/E-talet för Shanghai Pharmaceuticals Holding Co är 26,41.

Vilket P/S-tal har Shanghai Pharmaceuticals Holding Co 2024?

Det Shanghai Pharmaceuticals Holding Co KUV är 0,24.

Vilket AlleAktien kvalitetsscore har Shanghai Pharmaceuticals Holding Co?

AlleAktien Qualitätsscore för Shanghai Pharmaceuticals Holding Co är 7/10.

Hur hög är omsättningen för Shanghai Pharmaceuticals Holding Co 2024?

förväntade Shanghai Pharmaceuticals Holding Co omsättningen är 291,16 Mdk. CNY.

Hur stor är vinsten för Shanghai Pharmaceuticals Holding Co 2024?

förväntade Shanghai Pharmaceuticals Holding Co vinst är 2,70 Mdk. CNY.

Vad gör Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co Ltd is a leading Chinese pharmaceutical conglomerate that was founded in 1994. The company is headquartered in Shanghai and consists of various divisions, including pharmaceutical manufacturing, medication distribution, research and development, and chemical production. The company offers a wide range of products that are used in various fields of medicine. This includes antidepressants, analgesics, antipyretics, cardiology, and oncology. Additionally, the company also provides traditional Chinese medicine products and medical accessories. The pharmaceutical production division is one of the most important for the company. Here, Shanghai Pharmaceuticals produces a wide range of pharmaceuticals, including generics and patented products. The company has a strong research and development department specialized in producing highly effective drugs for various medical conditions. Another important area for the company is medication distribution. The company has a network of distribution partners that help distribute the products to different countries and regions. Shanghai Pharmaceuticals has branches in many countries and regions, including Thailand, Australia, and the USA. The company also has a strong presence in traditional Chinese medicine and offers a variety of products, including herbal blends and herbal capsules. These products have been used in Chinese culture for thousands of years and are popular among people worldwide. Shanghai Pharmaceuticals also has its own research and development department that is involved in the development of some very important drugs. The company specializes in developing drugs for chronic diseases such as diabetes, cancer, and cardiovascular diseases. In addition to pharmaceutical production, the company also offers some chemical products. Shanghai Pharmaceuticals manufactures various chemicals such as intermediates used in the pharmaceutical industry. These products are often used as raw materials for drug manufacturing. Overall, Shanghai Pharmaceuticals' business model is very successful, and the company is one of the leading Chinese companies in the pharmaceutical industry. The company has established itself as a reliable partner for various medical products and services, and is expected to continue growing in the future.

Hur hög är Shanghai Pharmaceuticals Holding Co-utdelningen?

Shanghai Pharmaceuticals Holding Co delar ut en utdelning på 0,42 CNY fördelad över utbetalningar per år.

Hur ofta betalar Shanghai Pharmaceuticals Holding Co utdelning?

Utbytet kan för närvarande inte beräknas för Shanghai Pharmaceuticals Holding Co eller så distribuerar bolaget inget utbyte.

Vad är Shanghai Pharmaceuticals Holding Co ISIN?

ISIN för Shanghai Pharmaceuticals Holding Co är CNE000000C82.

Vad är tickerkoden för Shanghai Pharmaceuticals Holding Co?

Ticker-symbolen för Shanghai Pharmaceuticals Holding Co är 601607.SS.

Hur mycket i utdelning betalar Shanghai Pharmaceuticals Holding Co?

Under de senaste 12 månaderna betalade Shanghai Pharmaceuticals Holding Co en utdelning på 0,61 CNY . Detta motsvarar en direktavkastning på ungefär 3,17 %. För de kommande 12 månaderna förväntas Shanghai Pharmaceuticals Holding Co betala en utdelning på 0,65 CNY.

Hur hög är utdelningsavkastningen för Shanghai Pharmaceuticals Holding Co?

Aktiens direktavkastning för Shanghai Pharmaceuticals Holding Co är för närvarande 3,17 %.

När betalar Shanghai Pharmaceuticals Holding Co utdelning?

Shanghai Pharmaceuticals Holding Co betalar ut dividenden kvartalsvis. Denna distribueras under månaderna augusti, augusti, augusti, augusti.

Hur säker är utdelningen från Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co betalade utdelning varje år under de senaste 19 åren.

Hur hög är utdelningen från Shanghai Pharmaceuticals Holding Co?

För de kommande 12 månaderna förväntas utdelningar uppgå till 0,65 CNY. Detta motsvarar en utdelningsavkastning på 3,36 %.

I vilken sektor befinner sig Shanghai Pharmaceuticals Holding Co?

Shanghai Pharmaceuticals Holding Co tilldelas sektorn 'Hälsa'.

Wann musste ich die Aktien von Shanghai Pharmaceuticals Holding Co kaufen, um die vorherige Dividende zu erhalten?

För att få den senaste utdelningen från Shanghai Pharmaceuticals Holding Co den 2023-07-20 på 0,61 CNY var du tvungen att ha aktien i ditt depå innan ex-dagen den 2023-07-20.

När betalade Shanghai Pharmaceuticals Holding Co ut den senaste dividenden?

Utdelningen av den senaste dividenden skedde den 2023-07-20.

Hur hög var utdelningen från Shanghai Pharmaceuticals Holding Co under år 2023?

Under år 2023 delade Shanghai Pharmaceuticals Holding Co ut 0,42 CNY i form av utdelningar.

I vilken valuta betalar Shanghai Pharmaceuticals Holding Co ut utdelningen?

Utdelningarna från Shanghai Pharmaceuticals Holding Co betalas ut i CNY.

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5,62
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,71	2,28
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	164,00	−131,00
−73,00	−119,00	−213,00	−312,00	−106,00	−373,00	−179,00	−445,00	−453,00	−373,00	−1 869,00	−1 981,00	−2 500,00	−6 182,00	−6 961,00	−7 413,00	−8 736,00	−9 641,00	−10 469,00	−15 349,00	−16 387,00	−17 141,00	−18 394,00	−17 530,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
−31,00	−31,00	−108,00	−261,00	−238,00	−95,00	−90,00	−124,00	−240,00	−268,00	−1 304,00	−1 629,00	−2 090,00	−2 457,00	−2 551,00	−2 802,00	−3 150,00	−3 576,00	−3 686,00	−5 638,00	−5 621,00	−5 849,00	−6 239,00	−8 853,00
0,16	0,15	0,07	0,10	0	0,06	0,07	0,63	0,49	0,29	1,91	2,21	1,77	1,15	0,97	1,34	1,35	1,95	2,65	3,14	6,02	6,84	5,06	4,74
−52,00	−141,00	−144,00	−279,00	−169,00	−254,00	−198,00	−180,00	−192,00	−90,00	−765,00	−573,00	−413,00	−708,00	−905,00	−1 291,00	−1 720,00	−2 119,00	−2 007,00	−1 943,00	−2 753,00	−3 010,00	−4 118,00	−2 684,00
−225,00	−120,00	−202,00	−99,00	−404,00	−234,00	−275,00	−13,00	−173,00	349,00	287,00	−2 988,00	−3 790,00	−174,00	−892,00	−1 844,00	−1 908,00	−2 889,00	−2 355,00	−7 692,00	−4 584,00	−1 705,00	−6 015,00	−12 473,00
−0,17	0,02	−0,06	0,18	−0,24	0,02	−0,08	0,17	0,02	0,44	1,05	−2,42	−3,38	0,53	0,01	−0,55	−0,19	−0,77	−0,35	−5,75	−1,83	1,30	−1,90	−9,79
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,31	0,27	−0,50	0,25	0,41	0,21	0,30	−0,25	−0,16	−0,04	−0,46	0,84	−1,40	−0,81	1,09	1,26	2,16	1,69	3,87	10,40	1,71	1,69	4,33	3,84
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,24	0,14	0,07	0,13	0,24	0,09	0,09	−0,40	−0,34	−0,27	−0,61	2,09	10,64	−2,25	−0,72	−0,95	0,64	0,65	2,31	7,53	−2,33	−1,26	1,57	12,14
−0,07	−0,06	0,63	0,00	0	0,01	0	−0,01	−0,02	−0,03	0,39	2,00	13,01	−0,28	−0,53	−0,63	0,10	0,67	0,47	−0,19	−1,45	−0,53	−0,09	11,40
0	−72,00	−49,00	−122,00	−166,00	−128,00	−210,00	−147,00	−154,00	−211,00	−537,00	−749,00	−969,00	−1 157,00	−1 284,00	−1 576,00	−1 628,00	−1 712,00	−2 032,00	−2 677,00	−2 584,00	−2 418,00	−2 675,00	−3 093,00
0,44	0,46	0,33	0,81	0,19	0,45	0,23	1,42	1,16	1,29	6,68	7,13	14,71	8,54	9,83	10,10	13,32	14,87	19,39	27,16	27,14	33,70	30,26	35,52
112,20	5,10	−79,00	−178,60	−169,10	−192,70	−125,10	452,50	294,10	195,20	1 145,80	1 637,60	1 358,90	441,90	68,30	44,20	−371,30	−172,60	641,50	1 192,10	3 269,30	3 834,70	942,55	2 058,50
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Direkta emissioner	117 174,96
Indirekta utsläpp från inköpt energi	333 124,49
Indirekta utsläpp inom värdekedjan.	—
CO₂-utsläpp	450 299,45
CO₂-reduktionsstrategi	✅
Kolenergi	❌
Kärnkraft	❌
Djurförsök	✅
Päls & Läder	—
Pesticider	—
Palmolja	—
Tobak	❌
Genteknik	❌
Klimatkoncept	—
Hållbart skogsbruk	—
Återvinningsföreskrifter	✅
Miljövänlig förpackning	✅
Farliga ämnen	✅
Bränsleförbrukning och effektivitet	❌
Vattenförbrukning och -effektivitet	✅

Andel kvinnliga anställda	50,3
Andel kvinnor i ledningen	—
Andel asiatiska anställda	—
Andel asiatisk ledning	—
Andel hispaniska/latinska anställda	—
Andel hispano/latino i ledningen	—
Andel svarta anställda	—
Andel svart ledning	—
Andel vita anställda	—
Andel vitt ledningsskap	—
Vuxeninnehåll	❌
Alkohol	❌
Försvarsindustri	—
Skjutvapen	❌
Hasardspel	❌
Militärkontrakt	❌
Mänskliga rättigheter-koncept	✅
Integritetspolicy	—
Arbetsmiljö och hälsa	✅
Katolsk	✅

Hållbarhetsrapport	✅
Stakeholder-engagemang	✅
Återuppringningspolicy	❌
Konkurrenslagstiftning	❌

Shanghai Pharmaceuticals Holding Co Ticker	Shanghai Pharmaceuticals Holding Co FIGI
601607:CH	BBG000BKDQ46
601607:CG	BBG000BKDQG3
601607:C1	BBG00709JCF1

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
4,41	4,53	4,60	5,20	7,24	9,79	10,82	10,70	12,64	13,92	16,55	31,26	38,53	54,90	68,08	78,22	92,40	105,52	120,77	130,85	159,08	186,57	191,91	215,82	231,98	260,30	291,16	322,76	357,23
-	2,65	1,43	13,21	39,10	35,24	10,52	−1,07	18,13	10,14	18,88	88,91	23,26	42,48	24,00	14,90	18,12	14,20	14,45	8,35	21,58	17,28	2,86	12,46	7,49	12,21	11,86	10,86	10,68
11,67	12,05	12,67	13,40	13,93	10,16	9,24	6,41	8,26	8,63	8,60	18,71	17,71	14,31	13,56	12,98	12,24	11,92	11,73	12,73	13,96	14,22	14,09	13,20	13,14	11,92	-	-	-
0,52	0,55	0,58	0,70	1,01	0,99	1,00	0,69	1,04	1,20	1,42	5,85	6,83	7,86	9,23	10,15	11,31	12,57	14,16	16,66	22,21	26,52	27,04	28,49	30,48	31,02	0	0	0
0,13	0,18	0,18	0,17	0,19	0,16	0,12	0,09	0,12	0,22	0,21	1,28	1,76	2,34	2,55	2,79	3,21	3,62	3,74	5,06	5,71	7,37	7,74	7,80	8,32	8,86	9,86	11,21	12,63
2,95	4,00	3,83	3,33	2,64	1,61	1,12	0,84	0,95	1,58	1,26	4,08	4,57	4,25	3,75	3,56	3,48	3,43	3,10	3,87	3,59	3,95	4,03	3,61	3,58	3,40	3,39	3,47	3,54
0,06	0,09	0,16	0,14	0,13	0,14	0,09	0,05	−0,04	0,07	0,08	1,30	1,27	2,04	2,05	2,24	2,59	2,88	3,20	3,52	3,88	4,08	4,50	5,09	5,62	3,77	2,70	3,04	3,50
-	56,67	72,34	−11,73	−11,89	8,73	−34,31	−43,33	−176,47	−269,23	24,24	1 481,71	−2,39	61,30	0,54	9,25	15,51	11,04	11,09	10,17	10,22	5,15	10,17	13,28	10,29	−32,92	−28,42	12,61	15,38
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,51	0,53	0,53	0,57	0,57	0,57	0,57	0,57	0,57	0,57	0,57	1,99	1,99	2,42	2,69	2,69	2,69	2,69	2,69	2,69	2,83	2,83	2,85	2,85	3,48	3,70	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Gör de bästa investeringarna i ditt liv

Aktiekurs

Aktiekurs

Ticker601607.SS

ISINCNE000000C82

Shanghai Pharmaceuticals Holding Co Aktie Omsättning, EBIT, Vinst CNE000000C82 ·

Omsättning, Vinst & EBIT

Förståelse av omsättning, EBIT och inkomst

Årlig analys och jämförelser

Använda förväntningarna för investeringen

Investmentinsikter

Shanghai Pharmaceuticals Holding Co Omsättning, vinst och EBIT-historik

Shanghai Pharmaceuticals Holding Co Aktie Nyckeltal

GuV

Omsättning och tillväxt

Bruttomarginal

EBIT och EBIT-marginal

Inkomst och tillväxt

Utestående aktier

Tolkning av årlig jämförelse

Förväntningar och prognoser

Balansräkning

Förståelse för balansräkningen

Tillgångar

Skulder

Eget kapital

År-för-år-analys

Tolkning av data

Shanghai Pharmaceuticals Holding Co Aktie Marginaler CNE000000C82 ·

Margen

Förståelse av bruttomarginal

EBIT-marginalanalys

Insikter i omsättningsmarginal

Tolka förväntningarna

Jämförande analys

Shanghai Pharmaceuticals Holding Co Marginalhistorik

Shanghai Pharmaceuticals Holding Co Aktiens omsättning, EBIT, vinst per aktie CNE000000C82 ·

Omsättning, EBIT och Vinst per aktie

Omsättning per aktie

EBIT per aktie

Inkomst per aktie

Förväntade värden

Shanghai Pharmaceuticals Holding Co Omsättning, vinst och EBIT per aktie historik

Shanghai Pharmaceuticals Holding Co Aktie och aktieanalys

Shanghai Pharmaceuticals Holding Co värdering baserad på historiskt P/E-tal, EBIT och P/S-tal

Shanghai Pharmaceuticals Holding Co Antal aktier CNE000000C82 ·

Omsättning, EBIT och Vinst per aktie

Omsättning per aktie

EBIT per aktie

Inkomst per aktie

Förväntade värden

Shanghai Pharmaceuticals Holding Co Aktiesplitter

Shanghai Pharmaceuticals Holding Co Aktieutdelning CNE000000C82 ·

Dividend

Översikt över Dividender

Tolkning och Användning

Investeringstrategi

Shanghai Pharmaceuticals Holding Co Utdelningshistorik

Shanghai Pharmaceuticals Holding Co Aktie Utdelningskvot CNE000000C82 ·

Utdelningsandel

Vad är den årliga utdelningsandelen?

Så tolkar du datan

Användning av datan för investeringar

Shanghai Pharmaceuticals Holding Co Utdelningskvotshistorik

Shanghai Pharmaceuticals Holding Co Vinstuppskattningar

Shanghai Pharmaceuticals Holding Co Resultatsöverraskningar

Eulerpool ESG Betyg för Shanghai Pharmaceuticals Holding Co-aktien

Eulerpool World ESG Rating (EESG©)

84/ 100

🌱 Environment

👫 Social

🏛️ Governance

Miljö (Environment)

Social (Social)

Företagsstyrning (Governance)

Shanghai Pharmaceuticals Holding Co Aktie Ägarstruktur

Shanghai Pharmaceuticals Holding Co Leveranskedja

Vanliga frågor om Shanghai Pharmaceuticals Holding Co-aktien

What values and corporate philosophy does Shanghai Pharmaceuticals Holding Co represent?

In which countries and regions is Shanghai Pharmaceuticals Holding Co primarily present?

Ticker
601607.SS

ISIN
CNE000000C82